Report Detail
Global Acute Myeloid Leukemia Biomarker Detection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4700330 |
- 21 May, 2026 |
- Global |
- 99 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Acute Myeloid Leukemia Biomarker Detection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Acute Myeloid Leukemia Biomarker Detection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Acute Myeloid Leukemia Biomarker Detection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Acute Myeloid Leukemia Biomarker Detection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Acute Myeloid Leukemia Biomarker Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Acute Myeloid Leukemia Biomarker Detection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Acute Myeloid Leukemia Biomarker Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Acute Myeloid Leukemia Biomarker Detection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V., Thermo Fisher Scientific, Inc., GeneTex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Acute Myeloid Leukemia Biomarker Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Next Generation Sequencing Technology
PCR Detection Technology
Market segment by Application
Hospital
Research Institutions
Other
Major players covered
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Genmark Saghlk Orinleri
Laboratory Corporation of America Holdings
Danaher
Medaysis Company
NeoGenomics Laboratories
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
GeneTex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acute Myeloid Leukemia Biomarker Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Acute Myeloid Leukemia Biomarker Detection, with price, sales quantity, revenue, and global market share of Acute Myeloid Leukemia Biomarker Detection from 2021 to 2026.
Chapter 3, the Acute Myeloid Leukemia Biomarker Detection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acute Myeloid Leukemia Biomarker Detection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Acute Myeloid Leukemia Biomarker Detection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Acute Myeloid Leukemia Biomarker Detection.
Chapter 14 and 15, to describe Acute Myeloid Leukemia Biomarker Detection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Next Generation Sequencing Technology
- 1.3.3 PCR Detection Technology
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Research Institutions
- 1.4.4 Other
- 1.5 Global Acute Myeloid Leukemia Biomarker Detection Market Size & Forecast
- 1.5.1 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity (2021-2032)
- 1.5.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Abbott Laboratories
- 2.1.1 Abbott Laboratories Details
- 2.1.2 Abbott Laboratories Major Business
- 2.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.1.4 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Abbott Laboratories Recent Developments/Updates
- 2.2 Bio-Rad Laboratories, Inc.
- 2.2.1 Bio-Rad Laboratories, Inc. Details
- 2.2.2 Bio-Rad Laboratories, Inc. Major Business
- 2.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.2.4 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
- 2.3 Genmark Saghlk Orinleri
- 2.3.1 Genmark Saghlk Orinleri Details
- 2.3.2 Genmark Saghlk Orinleri Major Business
- 2.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.3.4 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Genmark Saghlk Orinleri Recent Developments/Updates
- 2.4 Laboratory Corporation of America Holdings
- 2.4.1 Laboratory Corporation of America Holdings Details
- 2.4.2 Laboratory Corporation of America Holdings Major Business
- 2.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.4.4 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Laboratory Corporation of America Holdings Recent Developments/Updates
- 2.5 Danaher
- 2.5.1 Danaher Details
- 2.5.2 Danaher Major Business
- 2.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.5.4 Danaher Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Danaher Recent Developments/Updates
- 2.6 Medaysis Company
- 2.6.1 Medaysis Company Details
- 2.6.2 Medaysis Company Major Business
- 2.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.6.4 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Medaysis Company Recent Developments/Updates
- 2.7 NeoGenomics Laboratories
- 2.7.1 NeoGenomics Laboratories Details
- 2.7.2 NeoGenomics Laboratories Major Business
- 2.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.7.4 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 NeoGenomics Laboratories Recent Developments/Updates
- 2.8 QIAGEN N.V.
- 2.8.1 QIAGEN N.V. Details
- 2.8.2 QIAGEN N.V. Major Business
- 2.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.8.4 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 QIAGEN N.V. Recent Developments/Updates
- 2.9 Thermo Fisher Scientific, Inc.
- 2.9.1 Thermo Fisher Scientific, Inc. Details
- 2.9.2 Thermo Fisher Scientific, Inc. Major Business
- 2.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.9.4 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
- 2.10 GeneTex
- 2.10.1 GeneTex Details
- 2.10.2 GeneTex Major Business
- 2.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
- 2.10.4 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 GeneTex Recent Developments/Updates
3 Competitive Environment: Acute Myeloid Leukemia Biomarker Detection by Manufacturer
- 3.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Manufacturer (2021-2026)
- 3.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Acute Myeloid Leukemia Biomarker Detection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Acute Myeloid Leukemia Biomarker Detection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Acute Myeloid Leukemia Biomarker Detection Manufacturer Market Share in 2025
- 3.5 Acute Myeloid Leukemia Biomarker Detection Market: Overall Company Footprint Analysis
- 3.5.1 Acute Myeloid Leukemia Biomarker Detection Market: Region Footprint
- 3.5.2 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
- 3.5.3 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region
- 4.1.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2021-2032)
- 4.1.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2021-2032)
- 4.2 North America Acute Myeloid Leukemia Biomarker Detection Consumption Value (2021-2032)
- 4.3 Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value (2021-2032)
- 4.4 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value (2021-2032)
- 4.5 South America Acute Myeloid Leukemia Biomarker Detection Consumption Value (2021-2032)
- 4.6 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2021-2032)
- 5.2 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Type (2021-2032)
- 5.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2021-2032)
- 6.2 Global Acute Myeloid Leukemia Biomarker Detection Consumption Value by Application (2021-2032)
- 6.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2021-2032)
7 North America
- 7.1 North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2021-2032)
- 7.2 North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2021-2032)
- 7.3 North America Acute Myeloid Leukemia Biomarker Detection Market Size by Country
- 7.3.1 North America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2021-2032)
- 8.2 Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2021-2032)
- 8.3 Europe Acute Myeloid Leukemia Biomarker Detection Market Size by Country
- 8.3.1 Europe Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Market Size by Region
- 9.3.1 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Acute Myeloid Leukemia Biomarker Detection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2021-2032)
- 10.2 South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2021-2032)
- 10.3 South America Acute Myeloid Leukemia Biomarker Detection Market Size by Country
- 10.3.1 South America Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Market Size by Country
- 11.3.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Acute Myeloid Leukemia Biomarker Detection Market Drivers
- 12.2 Acute Myeloid Leukemia Biomarker Detection Market Restraints
- 12.3 Acute Myeloid Leukemia Biomarker Detection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Acute Myeloid Leukemia Biomarker Detection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Acute Myeloid Leukemia Biomarker Detection
- 13.3 Acute Myeloid Leukemia Biomarker Detection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Acute Myeloid Leukemia Biomarker Detection Typical Distributors
- 14.3 Acute Myeloid Leukemia Biomarker Detection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Acute Myeloid Leukemia Biomarker Detection. Industry analysis & Market Report on Acute Myeloid Leukemia Biomarker Detection is a syndicated market report, published as Global Acute Myeloid Leukemia Biomarker Detection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Acute Myeloid Leukemia Biomarker Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
